Table 1.
Characteristic | No. (%) of patients | Correlation | |||
---|---|---|---|---|---|
Total | ITM2A high | ITM2A low | Chi-square | p value | |
Age in years | 1208 | 6.048 | 0.0139 | ||
≤ 60 | 285 | 362 | |||
> 60 | 208 | 353 | |||
ER status | 1145 | 3.016 | 0.0824 | ||
Positive | 382 | 504 | |||
Negative | 96 | 163 | |||
PR status | 1142 | 6.734 | 0.0095 | ||
Positive | 340 | 427 | |||
Negative | 136 | 239 | |||
HER2 level | 2.726 | 0.2559 | |||
1+ | 122 | 160 | |||
2+ | 75 | 134 | |||
3+ | 39 | 57 | |||
T classification | 1205 | 12.67 | 0.0018 | ||
T1 | 145 | 164 | |||
T2 | 256 | 443 | |||
T3/T4 | 92 | 105 | |||
N classification | 1185 | 8.345 | 0.0394 | ||
N0 | 261 | 300 | |||
N1 | 220 | 191 | |||
N2 | 68 | 64 | |||
N3 | 49 | 32 | |||
Stage | 1199 | 14.62 | 0.0022 | ||
I | 92 | 110 | |||
II | 254 | 432 | |||
III | 134 | 141 | |||
Other | 11 | 25 |
ER estrogen receptor, PR progesterone receptor, HER2 receptor tyrosine-protein kinase erbB-2